Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H

被引:52
|
作者
Logrip, Marian L. [1 ,2 ]
Janak, Patricia H. [1 ,2 ,3 ]
Ron, Dorit [1 ,2 ,3 ]
机构
[1] Ernest Gallo Res Ctr, Emeryville, CA 94608 USA
[2] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
关键词
Dynorphin; Kappa opioid receptor; Reward; Ethanol; CPP; CONDITIONED PLACE PREFERENCE; STRIATAL DOPAMINE LEVELS; MESSENGER-RNA CONTENT; BRAIN-REGIONS; COCAINE; ACTIVATION; DYNORPHIN; STRESS; SENSITIZATION; INCREASES;
D O I
10.1016/j.alcohol.2009.05.001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Alcoholism is a pervasive social problem, and thus understanding factors that regulate alcohol (ethanol) reward is important for designing effective therapies. One putative regulatory system includes the kappa opioid receptor (KOR) and its endogenous ligand, dynorphin. Previously, we demonstrated that acute ethanol increased preprodynorphin expression via brain-derived neurotrophic factor (BDNF) in striatal neurons, and that blockade of the KOR attenuated decreases in ethanol intake observed following increased expression of BDNF. As high doses of KOR agonists can generate an aversive state, we hypothesized that endogenous dynorphin may regulate ethanol intake by interfering with the rewarding properties of ethanol. We found that low, nonaversive doses of the KOR agonist U50,488H blocked the rewarding properties of ethanol during conditioning, thus impairing the acquisition of conditioned place preference. Importantly, we demonstrate that U50,488H also inhibited the conditioned increase in locomotor activation normally observed in the ethanol-paired chamber on test day. Taken together, these data indicate that the KOR/dynorphin system may acutely regulate ethanol intake via inhibition of the rewarding properties of ethanol. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [31] Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats
    Xuan Zhou
    Dongjuan Wang
    Yuyang Zhang
    Jinxia Zhang
    Dingcheng Xiang
    Haichang Wang
    BMC Endocrine Disorders, 15
  • [32] SPINALLY MEDIATED ANTINOCICEPTIVE ACTIVITY OF THE KAPPA-AGONISTS ETHYLKETOCYCLAZOCINE AND U50,488H IN MICE
    DUNN, RW
    FIELDING, S
    HO, C
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1722 - 1722
  • [33] ATTENUATION OF THE ANTINOCICEPTIVE ACTION OF THE SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, U-50,488H BY ICS-205-930
    HO, BY
    TAKEMORI, AE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 178 (03) : 371 - 373
  • [34] INHIBITION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA SYNTHESIS FOLLOWING TREATMENT OF MACROPHAGES WITH THE KAPPA-OPIOID AGONIST U50,488H
    BELKOWSKI, SM
    ALICEA, C
    EISENSTEIN, TK
    ADLER, MW
    ROGERS, TJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 273 (03): : 1491 - 1496
  • [35] EFFECT OF CHRONIC ADMINISTRATION OF NALTREXONE ON BRAIN MU-OPIOID AND KAPPA-OPIOID RECEPTORS AND RESPONSES TO U-50,488H, A KAPPA-OPIOID RECEPTOR AGONIST IN THE MOUSE
    VILLAR, VM
    RAHMANI, NH
    BHARGAVA, HN
    FASEB JOURNAL, 1995, 9 (03): : A102 - A102
  • [36] EFFECTS OF U50,488H ON LOCOMOTOR-ACTIVITY IN THE HAMSTER
    SCHNUR, P
    WALKER, JM
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) : 813 - 816
  • [37] DIFFERENTIAL ANTAGONISM OF MU AGONISTS BY U50,488H IN THE RAT
    PORRECA, F
    TORTELLA, FC
    LIFE SCIENCES, 1987, 41 (23) : 2511 - 2516
  • [38] Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects
    van de Wetering, Ross
    Vu, Loan Y.
    Kornberger, Lindsay D.
    Luo, Dan
    Scouller, Brittany
    Hong, Sheein
    Paton, Kelly
    Prisinzano, Thomas E.
    Kivell, Bronwyn M.
    MOLECULES, 2025, 30 (03):
  • [39] Effects of U-50,488H, a κ-opioid receptor agonist, on the learned helplessness model of depression in mice
    M. Ukai
    M. Suzuki
    T. Mamiya
    Journal of Neural Transmission, 2002, 109 : 1221 - 1225
  • [40] THE INTERACTION BETWEEN KAPPA-OPIOID AGONIST, U-50,488H, AND KAINIC ACID - BEHAVIORAL AND HISTOLOGICAL ASSESSMENTS
    LASON, W
    SIMPSON, JN
    MCGINTY, JF
    BRAIN RESEARCH, 1989, 482 (02) : 333 - 339